RejuvenRx Inc.
PrivateLast Round
Grant
Sep 21, 2026
Total Funding Raised
$1.83M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
RejuvenRx Inc. is a biotechnology company developing small molecule-based targeted therapies focusing on stem cell biology to treat cancer and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RejuvenRx Inc. Comparables
Compare RejuvenRx Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GluBio Therapeutics | 81% | |
| SEED Therapeutics | 78% | |
| Degron Therapeutics | 78% |
RejuvenRx Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 21, 2026 | ||||
| Grant | Apr 9, 2024 | ||||
| Seed | Jan 27, 2023 |
RejuvenRx Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Stem Cell Network | Grant |
| IRICoR | Seed |
| Consortium Québécois sur la découverte du médicament | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
$733K grant received from Stem Cell Network.
- Apr 9, 2024
Secured $1.1M from Canadian Institutes of Health Research and others.
Recent news
Latest coverage and updates
- receives_financingSep 22, 2026
RejuvenRx Inc. received financing of $1M on Sep 21st '26.
RejuvenRx Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RejuvenRx Inc.'s valuation, stock price, and market status.
Is RejuvenRx Inc. a public or private company?
RejuvenRx Inc. is a private company.
What is the current stock price of RejuvenRx Inc.?
RejuvenRx Inc. is a private company with no public stock price. Caplight tracks RejuvenRx Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is RejuvenRx Inc. worth (valuation)?
Valuation information for RejuvenRx Inc. is not publicly available.
Can I buy RejuvenRx Inc. stock?
RejuvenRx Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RejuvenRx Inc.'s last funding round?
RejuvenRx Inc.'s most recent funding round was Grant on September 21, 2026.
Who are the main investors in RejuvenRx Inc.?
Key investors in RejuvenRx Inc. include Stem Cell Network, IRICoR.
Will RejuvenRx Inc. IPO soon?
No public IPO plans have been announced for RejuvenRx Inc..
How can I track RejuvenRx Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RejuvenRx Inc.'s secondary market activity and sign up for updates.